Today: 7 February 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Australia Stock Market Holiday Schedule: ASX Trading Hours for Christmas 2025 and New Year’s Day 2026

Australia Stock Market Holiday Schedule: ASX Trading Hours for Christmas 2025 and New Year’s Day 2026

Australia’s sharemarket is heading into Christmas with momentum and a shorter trading week — and that makes the ASX holiday timetable more important than usual for investors, traders, SMSFs and anyone managing settlement deadlines. The Australian Securities Exchange (ASX) will close for Christmas Day (Thursday, 25 December 2025) and Boxing Day (Friday, 26 December 2025), and it will also be closed for New Year’s Day (Thursday, 1 January 2026). The market also runs early closes on Christmas Eve (Wednesday, 24 December 2025) and New Year’s Eve (Wednesday, 31 December 2025). Australian Securities Exchange+1 With the ASX 200 pushing higher into the holiday period and analysts pointing to a “Santa rally” tone in
23 December 2025
·····
U.S. Stock Market Holiday Schedule: NYSE and Nasdaq Hours for Christmas 2025 and New Year’s Day 2026

U.S. Stock Market Holiday Schedule: NYSE and Nasdaq Hours for Christmas 2025 and New Year’s Day 2026

With Christmas and New Year’s arriving back-to-back on the calendar, U.S. investors are heading into one of the year’s most timing-sensitive stretches—where a single afternoon can be the difference between getting a trade filled before the bell or waiting an extra day. For Christmas 2025, U.S. stock exchanges run a shortened session on Christmas Eve (Wednesday, Dec. 24, 2025) and then close for Christmas Day (Thursday, Dec. 25, 2025). For New Year’s Day 2026, markets are closed on Thursday, Jan. 1, 2026, while New Year’s Eve (Wednesday, Dec. 31, 2025) remains a regular trading day for stocks. New York Stock Exchange+1 Adding to the year-end confusion: in the past
23 December 2025
······
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 23.12.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-23-12-2025/#live”,”headline”:”Stock Market Today 23.12.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-12-23T00:00:02-05:00″,”dateModified”:”2025-12-24T00:00:03-05:00″,”coverageStartTime”:”2025-12-23T00:00:02-05:00″,”coverageEndTime”:”2025-12-24T00:00:03-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-23-12-2025/#live/u/ca8c79b4543e4212″,”headline”:”MarketSmith India Stock Picks: Bajaj Auto and SJS Enterprises Amid Range-Bound Nifty”,”articleBody”:”Indian benchmarks ended mixed as the Sensex slipped 43 points to 85,524.84 while the Nifty 50 closed at 26,177.15, in a quiet, range-bound session. The BSE Midcap rose 0.07% and Smallcaps gained 0.38%, with Financials and FMCG leading gains and IT soft on concerns about global tech spend. Heavyweights like Infosys, Bharti Airtel and ICICI Bank were among the top drags, while HDFC Bank and ITC provided support. MarketSmith India issued
23 December 2025
······
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 22.12.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-22-12-2025/#live”,”headline”:”Stock Market Today 22.12.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-12-22T00:00:02-05:00″,”dateModified”:”2025-12-23T00:00:02-05:00″,”coverageStartTime”:”2025-12-22T00:00:02-05:00″,”coverageEndTime”:”2025-12-23T00:00:02-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-22-12-2025/#live/u/d07e7faa78701276″,”headline”:”Anfield Energy Inc. (0ADN.F) Stock Forecast December 2025: Oversold Bounce Analysis”,”articleBody”:”Anfield Energy Inc. (0ADN.F) trades at €0.065 on Germanyu0027s XETRA, with a stagnant session and oversold setup. Technicals show an RSI of 0 and moderate ATR around 0.09, suggesting a potential bounce as selling pressure wanes. Meyka AI scores 68.0 (B, HOLD), while the company reports a market cap of €81.12 million and a negative EPS of -€0.47, yielding a P/E of -0.138 but a robust current ratio of 6.69, cautioning about
22 December 2025
····
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of U.S. drug-pricing headlines that could reshape sentiment into 2026. Investopedia+4Reuters+4Reuters+4 The setup matters because next week’s market structure will be unusual: U.S. stock markets are scheduled to close early on Wednesday, December 24 (1:00 p.m. ET) and remain closed on
21 December 2025
······
Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Christmas week is usually about thin liquidity and shorter trading hours, not blockbuster headlines. But pharma and biotech stocks head into the final full week of the year with a rare mix of policy shockwaves, deal-making, and FDA-driven volatility—all clustered around Dec. 19–21, 2025. From the White House’s sweeping “most-favored-nation” (MFN) push on U.S. drug prices to BioMarin’s largest-ever acquisition and fresh FDA approvals, the setup into year-end has become more headline-sensitive than the calendar would suggest. Here’s what investors and traders should be watching in pharma stocks in the week ahead. Christmas week trading: shorter sessions, fewer buyers, faster
21 December 2025
···········
Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Nuclear stocks head into the Christmas week with two forces pulling in opposite directions: a holiday-thinned trading calendar that can exaggerate moves, and a still-bullish long-term narrative tied to grid reliability, AI data center power demand, and government-backed “reshoring” of the nuclear fuel cycle. New York Stock Exchange+2Investopedia+2 Across Dec. 19–21, 2025, the story wasn’t a single headline—it was a cluster of catalysts: uranium holding near the psychologically important $80/lb area, fresh “uranium renaissance” commentary around forward pricing, a major enrichment supply-chain update from Centrus Energy (LEU), renewed debate over small modular reactor (SMR) names like Oklo (OKLO) and NuScale
21 December 2025
·····
Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Holiday-shortened trading weeks can be deceptively eventful for space and satellite tech stocks: lower liquidity tends to amplify moves, while “hard” catalysts like contract awards, launch milestones, and regulatory headlines still land on the tape. Heading into the week of Dec. 22–26, 2025, investors are digesting a tightly packed stream of headlines and fresh analyst takes published Dec. 19–21—with Rocket Lab (RKLB), AST SpaceMobile (ASTS), Intuitive Machines (LUNR), EchoStar (SATS), and Planet Labs (PL) among the most-discussed names. Below is what moved the group over Dec. 19–21, 2025, and what to watch next as space and satellite stocks set up
21 December 2025
········
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military tech stocks are heading into the Christmas-shortened trading week with fresh catalysts from December 19–21 that reinforce a clear narrative: modern defense spending is tilting toward space-based sensing, low-cost drones, and software-heavy systems—while investors debate how much of that shift is already priced into 2025’s big gains. Barron’s+3Air & Space Forces Magazine+3Reuters+3 With U.S. equity markets set to close early on Wednesday, December 24, and remain closed on Thursday, December 25, any headlines on contracts, policy, or analyst calls can have an outsized impact in thinner liquidity—especially for smaller-cap “pure-play” defense tech names. Investopedia+2New York Stock Exchange+2 Below is
21 December 2025
········
Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data center stocks head into the week of December 22, 2025 at an unusual intersection: the AI infrastructure buildout is still accelerating, but markets are getting far less forgiving about how it’s funded, how quickly it pays back, and whether the power grid can keep up. That tension was on full display from December 19–21—a three-day stretch that brought fresh evidence of a global data center construction wave, rising regulatory and political pushback on electricity costs, and renewed questions about the sustainability of debt-heavy AI expansion. At the same time, parts of the AI trade bounced late in the week
21 December 2025
····
Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Dec. 21, 2025 — Software and platform stocks head into the Christmas week balancing two powerful forces: a thinner, holiday-shortened market that can amplify price swings, and a still-evolving narrative around the AI buildout—specifically, when massive infrastructure spending turns into measurable profits. By Friday’s close, investors were once again talking about a potential “Santa Claus rally,” but the setup feels different than in a typical year. The sector’s winners are increasingly defined by platform leverage (cloud ecosystems, cybersecurity suites, and data/AI tooling) rather than simple “growth at any price.” At the same time, several high-growth SaaS names face tougher comparisons
21 December 2025
···········
Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank stocks head into Christmas week with a familiar year-end setup: lighter liquidity, a compressed calendar, and just enough macro and policy headlines to move interest rates—and, by extension, the entire financial sector. Over Dec. 19–21, 2025, the storylines that matter most for banks crystallized quickly: Federal Reserve officials pushed back on near-term rate-cut urgency, a fresh batch of delayed U.S. data is finally set to hit the tape, and banks on both sides of the Atlantic kept returning cash to shareholders through buybacks while dealmaking and trading revenues stayed in focus. Reuters+4Reuters+4Reuters+4 Below is what bank-stock investors and financials
21 December 2025
···
1 … 38 39 40 41 42 … 586

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Go toTop